Exploring the Potential of Cannabis: Join the Conversation during National Pain Week 2023

Monday 24 July marks the start of National Pain Week 2023, a crucial awareness event dedicated to shedding light on the challenges faced by those living with chronic pain in Australia.

This week-long campaign lead by Chronic Pain Australia , to promote Awareness, Accessibility, and Affordability for individuals coping with chronic pain, is the national voice for the 3.6 million Australians living with chronic pain. We applaud the group of committed volunteers advocating to reduce the social and economic barriers to those who live with chronic pain.

As a leading provider of medicinal cannabis education for AHPRA-registered health professionals in Australia, Viz Medicinal is committed to advancing knowledge and insights that improve patient care and outcomes. We firmly believe that education is a powerful tool in the pursuit of enhanced pain management strategies.

It's exciting to see Chronic Pain Australia collaborating with Australia's leading medicinal cannabis companies Cymra Life Sciences , Promethean BioPharma Ltd and MedReleaf Australia to shine a light on the potential for cannabis to be a #painchanger. Sign up for the the Deep Dive into Medicinal Cannabis: 4-part video series kicking off tonight at 5:30pm AEST here.

In line with National Pain Week's goal of promoting Awareness, we are proud to present an exclusive webinar for AHPRA-registered health professionals titled "Microdosing Medicinal Cannabis for Pain Management" next Tuesday, August 1st, 2023 at 6:30pm AEST.

This enlightening session will be hosted by esteemed expert Dr. Orit Holtzman, Co-founder and Director of Leura Wellness and President of the The Australian and New Zealand College of Cannabinoid Practitioners .

Sign up to learn about the transformative potential of microdosing here: https://microdosewebinar.eventbrite.com.au

During this interactive session, Dr. Holtzman will delve into the transformative potential of microdosing using a metered-dose inhaler, a groundbreaking technology for precise cannabis delivery in pain reduction. Health professionals will gain comprehensive insights into the Syqe Medical inhaler's method of action and product information, allowing them to personalise treatment plans tailored to patients' unique needs.

"I'm excited to share how microdosing cannabis using a metered-dose inhaler has the potential to transform pain management for improved patient outcomes," Dr Holtzman said.

At Viz Medicinal, we believe that education empowers us to take meaningful action in addressing complex issues. By participating in upcoming webinars, health professionals can take a front-row seat in exploring innovative pain management solutions that have the potential to revolutionise the way we address chronic pain.

Don't miss out on this invaluable opportunity to learn about transformative pain management solutions. Sign up today at vizmedicinal.com.au and be part of the movement to enhance patient care and outcomes.